Skip to main content

Table 3 Annual per patient cost ($) of CKD (RRT&NRRT) treatment in Asian countries

From: The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review

Cost centers

Singapore (40, 41)

Japan

(43)

Hong Kong (29)

Korea

(28)

Taiwan

(37)

China

(30, 36)

Jordan

(13)

Indonesia

(33)

Iran

(42)

Vietnam

(31)

Lebanon (12, 38)

Palestine (27)

India (32, 35, 39, 43)

 

No of studies

2

1

1

1

1

4

1

1

1

1

2

1

4

 

GDP per capita USD (2023)

87,884

52,120

51,168

33,147

32,339

14,096

4851

4691

4234

4122

4003

1129

2650

 

Renal replacement therapy cost

hemodialysis

 

45,876

52,307

64,145

23,479

18,032

13,986

6249

  

14,117

19,833

5490

 

Peritoneal dialysis

  

27,529

43,005

19,300

15,888

 

3053

  

22,613

   

Transplantation surgery

        

1024

  

7192

1943

 

Transplantation total expense (pre + post-surgery)

   

109,403

 

24,928

      

10,939

 

AVF creation

      

181

       

hospitalization

 

28,235

   

404

    

1372

 

581

 

medications

     

2175

1023

  

7.17

328

   

lab investigations

      

647

  

51

564

   

physician visits

 

366

       

6

129

   

transportation

   

1711

  

832

  

24.77

48

 

273

 

Total direct cost of ESRD (RRT)

4574

  

18,668

29,013

6848

16,669

  

3489

5945

 

6344

 

Non-renal replacement therapy cost

CKD stage 1

1240

2236

       

27

    

CKD stage

2

2698

1261

       

36.11

    

CKD stage

3

4189

2507

       

81.28

    

CKD stage

4

5519

2963

   

4534

   

1016

    

Total direct cost (NRRT)

3412

2241

       

290

  

1500

 
  1. Per patient per year mean average cost reported in US dollars ($) *GDP; gross domestic product per capita